FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,147,798 | -56.3% | 212,864 | -2.9% | 0.12% | -56.8% |
| Q3 2022 | $4,911,000 | -27.4% | 219,146 | -19.7% | 0.28% | -12.8% |
| Q2 2022 | $6,766,000 | -29.0% | 273,033 | +11.0% | 0.33% | -13.9% |
| Q1 2022 | $9,534,000 | -34.9% | 245,916 | -1.7% | 0.38% | -26.9% |
| Q4 2021 | $14,640,000 | -5.3% | 250,212 | -4.0% | 0.52% | -8.9% |
| Q3 2021 | $15,455,000 | -46.9% | 260,756 | -22.3% | 0.57% | -44.8% |
| Q2 2021 | $29,112,000 | -8.1% | 335,427 | -12.7% | 1.04% | +0.2% |
| Q1 2021 | $31,691,000 | -10.0% | 384,362 | -0.8% | 1.03% | -16.6% |
| Q4 2020 | $35,220,000 | +169.6% | 387,327 | +18.5% | 1.24% | +135.6% |
| Q3 2020 | $13,064,000 | – | 326,844 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |